Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 19:15:139-146.
doi: 10.2147/OPTO.S411390. eCollection 2023.

Patients' Satisfaction with Topical Anti-Glaucoma Medications and Associated Factors at Gondar University Tertiary Eye Care and Training Center, Northwest Ethiopia, 2021

Natnael Yeneneh Belie  1 , Fisseha Admassu Ayele  2 , Belayneh Mengist  3 , Abiy Maru Alemayehu  1 , Abel Sinshaw Assem  1 , Sofonias Addis Fekadu  1 , Betelhem Temesgen Yibekal  1
Affiliations

Patients' Satisfaction with Topical Anti-Glaucoma Medications and Associated Factors at Gondar University Tertiary Eye Care and Training Center, Northwest Ethiopia, 2021

Natnael Yeneneh Belie et al. Clin Optom (Auckl). .

Abstract

Background: Glaucoma is one of the leading cause of global irreversible blindness if left untreated. Satisfaction is a multifaceted outcome based on sufficient information and encouragement from the practitioner and based on the medications' nature. Determining patients' satisfaction is essential to increase their courage in their long-time follow-up of medical care.

Objective: To assess Patients' satisfaction with topical anti-glaucoma medications and associated factors among glaucoma patients at Gondar University Tertiary Eye Care and Training Center, Northwest Ethiopia.

Methods: Hospital-based cross-sectional study was conducted from June 30 to August 27, 2021, among 395 glaucoma patients at Gondar University Tertiary Eye Care and Training Center. Data was entered into Epi info version 7 and exported to SPSS version 26 software for analysis. A Binary logistic regression model was used to determine factors associated with satisfaction with topical anti-glaucoma medications. Statistical significance was considered when p-value < 0.05.

Results: A total of 395 study subjects participated in the study with a response rate of 93.38%. The overall satisfaction with topical anti-glaucoma medication was 62.5% with 95% CI: (57.5-67.8%). The absence of ocular side effects (AOR=5.39, 95% CI: 2.35-12.37) and the absence of ocular surface diseases (AOR=4.12, 95% CI: 1.69-10.09) were significantly associated with patient satisfaction.

Conclusion: More than half of the study participants were satisfied with topical anti-glaucoma medications. The absence of ocular side effects and absence of Ocular surface diseases were significantly associated with patient satisfaction with anti-glaucoma medication.

Keywords: Gondar; Northwest Ethiopia; anti-glaucoma medication; satisfaction.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Chow JT, Hutnik CM, Solo K, Malvankar-Mehta MS. When is evidence enough evidence? A systematic review and meta-analysis of the trabectome as a solo procedure in patients with primary open-angle glaucoma. J Ophthalmol. 2017;2017. doi:10.1155/2017/2965725 - DOI - PMC - PubMed
    1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224 - DOI - PMC - PubMed
    1. Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013 - DOI - PubMed
    1. Foo VHX, Tan SEM, Chen DZ, et al. Areas and factors associated with patients’ dissatisfaction with glaucoma care. Clin Ophthalmol. 2017;11:1849. doi:10.2147/OPTH.S138668 - DOI - PMC - PubMed
    1. Lemij HG, Hoevenaars JG, van der Windt C, Baudouin C. Patient satisfaction with glaucoma therapy: reality or myth? Clin Ophthalmol. 2015;9:785. doi:10.2147/OPTH.S78918 - DOI - PMC - PubMed